PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1419028
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1419028
Pharmaceutical Regulatory Affairs Market, By Services, By Category, By Product stage, By Indication, Service Provider, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
REPORT HIGHLIGHT
Pharmaceutical Regulatory Affairs Market size was valued at USD 13,815.4 Million in 2022, expanding at a CAGR of 8.5% from 2023 to 2030.
Pharmaceutical Regulatory Affairs professionals play a crucial role in ensuring compliance with laws and regulations within the industry. Their main objective is to guarantee the safety, effectiveness, and quality of pharmaceutical products. The pharmaceutical industry is highly regulated, and regulatory affairs professionals are essential in the development of drugs, acting as the primary communication channel between the company and regulatory agencies such as the FDA. They are responsible for staying updated on the ever-expanding and intricate regulatory landscape. In addition to their knowledge of legal and regulatory environments, these professionals also possess expertise in clinical research protocols.
Pharmaceutical Regulatory Affairs Market- Market Dynamics
The growth of the Pharmaceutical Regulatory Affairs market is anticipated to be driven by the expansion of Pharma and Biotech industries, as well as the increasing emphasis on drug development.
Pharmaceutical companies are actively pursuing global expansion of their market presence. In order to enter new markets, they must adhere to various regulatory requirements in different countries. The role of regulatory affairs professionals is vital in navigating these intricate regulatory landscapes, ensuring that products meet the necessary standards and obtain approval for sale. According to Pharmaceutical Statistics, the revenue generated by the U.S. pharmaceutical industry reached USD 550 billion in 2021. Additionally, Americans spent USD 576.9 billion on medicine in the same year. The increasing focus on drug discovery and development has resulted in a higher number of new drug applications and submissions to regulatory agencies. Currently, there are more than 40,000 FDA-approved drugs available in the market. The growing emphasis on advanced therapies, such as cell and gene therapies, along with personalized medicine, presents opportunities for the regulatory affairs market. However, it is important to note that stringent regulatory requirements may pose challenges and restrict the growth of the market.
Pharmaceutical Regulatory Affairs Market- Key Insights
- As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.5% over the forecast period (2023-2030)
- Based on Services segmentation, Regulatory Writing & Publishing was predicted to show maximum market share in the year 2022
- Based on Category segmentation, Drugs was the leading type in 2022
- Based on Product stage segmentation, Clinical Studies was the leading type in 2022
- Based on Indication segmentation, Oncology was the leading type in 2022
- Based on Service providers segmentation, Outsourcing was the leading type in 2022
- On the basis of region, North America was the leading revenue generator in 2022
Pharmaceutical Regulatory Affairs Market- Segmentation Analysis:
The Global Pharmaceutical Regulatory Affairs Market is segmented on the basis of Services, Category, Product stage, Indication, Service provider and Region.
The market is divided into five categories based on Services: Regulatory Consulting, Legal Representation, Regulatory Writing & Publishing (Writing, Publishing), Product Registration & Clinical Trial Category and Other Services. Regulatory Writing & Publishing holds a significant position in the market. It plays a crucial role in Regulatory Affairs, encompassing the preparation, compilation, and submission of diverse regulatory documents necessary for product approval and post-marketing activities. The responsibility of regulatory writers is to transform intricate scientific and clinical data into well-structured and comprehensive documents that adhere to regulatory standards. On the other hand, regulatory publishing involves the formatting, organizing, and submission of these documents in the specified electronic formats to health authorities.
The market is divided into two categories based on Category: Drugs and Biologics. Drugs segment dominates the market. The The Pharmaceutical Regulatory Affairs sector plays a crucial role in the process of introducing drugs to the market. It involves navigating through regulatory pathways, ensuring adherence to regulations, and facilitating effective communication with health authorities. This ensures that drugs are developed and marketed in a way that prioritizes the safety and effectiveness for patients.
The market is divided into three categories based on Product stage: Preclinical, Clinical Studies and PMA.The market is primarily dominated by the Clinical Studies segment. Regulatory professionals play a crucial role in ensuring that clinical trials comply with regulatory standards, thereby facilitating the creation of pharmaceutical products that are both safe and effective. Acting as intermediaries between clinical trial sponsors and regulatory authorities, they play a pivotal role in the introduction of new therapies to the market.
The market is divided into four categories based on Indication: Oncology, Neurology, Cardiology, Immunology and Others. Oncology segment dominates the market. Regulatory Affairs experts work closely with oncology drug development teams to formulate regulatory strategies that tackle the distinctive obstacles encountered in the development of cancer treatments. Oncology drugs have the potential to receive special designations like Fast Track, Breakthrough Therapy, or Orphan Drug status. Regulatory Affairs professionals play a crucial role in securing these designations to accelerate the development and regulatory procedures.
The market is divided into two categories based on Service Provider: In-house and Outsourcing. The market is primarily dominated by the outsourcing segment. Within this segment, outsourcing firms are responsible for managing the compilation, formatting, and submission of regulatory documents to health authorities. Additionally, companies have the option to outsource the implementation of new technologies in regulatory processes, such as electronic submission tools or artificial intelligence applications.
Pharmaceutical Regulatory Affairs Market- Geographical Insights
This market is geographically widespread across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided based on the countries involved in business activities. The Asia Pacific region is expected to lead the market growth, primarily due to its increasing focus on Advanced Therapies and Personalized Medicine. In this region, there is a significant emphasis on advanced therapies such as biologics, gene therapies, and personalized medicine. Regulatory affairs professionals play a vital role in facilitating the development, registration, and market access of these innovative therapies, thereby contributing to the overall growth of the regulatory affairs market. With a population of over 1.4 billion, China faces an urgent demand for the development of new therapeutics, especially gene therapies, as it has an estimated 57 million people with genetic diseases and over 4 million new cancer cases annually. During forecast period, Europe and North America are also expected to drive market growth due to the increasing number of clinical trials conducted in these regions and the growing presence of biopharmaceutical companies venturing into these areas.
Pharmaceutical Regulatory Affairs Market- Competitive Landscape:
The pharmaceutical industry is a constantly evolving and research-driven sector that is heavily influenced by a complex set of regulations. These regulations aim to foster research and innovation in drug design and production, safeguard consumers from potential harm caused by drugs, and regulate the expenditure on drugs in both public and private sectors. However, achieving these objectives can sometimes create conflicts and necessitate a careful balance between the interests of producers and consumers. To navigate this regulatory landscape, specialized consulting firms, contract research organizations (CROs), and in-house departments of pharmaceutical companies offer regulatory affairs services. These services provide a cost-effective and convenient option for equipping consumer organizational teams with the necessary tools and knowledge to excel as regulatory professionals and stay ahead of the competition. In this market, competition may arise in the form of the development and adoption of technologies that streamline regulatory compliance processes, such as regulatory information management systems (RIMS) and electronic submission tools.
Recent Developments:
On September 2023, Freyr Solutions, the leading global provider of Regulatory solutions and services, is pleased to announce its strategic partnership with PKG Group LLC. This collaboration has resulted in the successful submission of PKG Group's Type III Drug Master File (DMF) to the US Food and Drug Administration (US FDA). Freyr has provided a comprehensive range of services for the Type III DMF registration support, including a thorough analysis of the documents, compilation of the dossier in eCTD format, and expert guidance throughout the submission process. Additionally, Freyr has offered assistance in managing queries from the US FDA, ensuring a seamless and efficient submission process.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL PHARMACEUTICAL REGULATORY AFFAIRS MARKET KEY PLAYERS
- Freyr
- IQVIA Inc
- ICON plc
- WuXi AppTec
- Charles River Laboratories
- Labcorp Drug Development
- Parexel International Corporation
- Pharmalex GmbH
- Pharmexon
- Genpact
GLOBAL PHARMACEUTICAL REGULATORY AFFAIRS MARKET, BY SERVICES
- Regulatory Consulting
- Legal Representation
- Regulatory Writing & Publishing (Writing, Publishing)
- Product Registration & Clinical Trial Categorys
- Other
GLOBAL PHARMACEUTICAL REGULATORY AFFAIRS MARKET, BY CATEGORY
- Drugs
- Innovator
- Generics
- Biologics
- Biotech
- ATMP
- Biosimilars
GLOBAL PHARMACEUTICAL REGULATORY AFFAIRS MARKET, BY PRODUCT STAGE
- Preclinical
- Clinical Studies
- PMA
GLOBAL PHARMACEUTICAL REGULATORY AFFAIRS MARKET, BY INDICATION
- Oncology
- Neurology
- Cardiology
- Immunology
- Others
GLOBAL PHARMACEUTICAL REGULATORY AFFAIRS MARKET, BY SERVICE PROVIDERS
- In-house
- Outsourcing
GLOBAL PHARMACEUTICAL REGULATORY AFFAIRS MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Table of Contents
1. Pharmaceutical Regulatory Affairs Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Pharmaceutical Regulatory Affairs Market Snippet by Service
- 2.1.2. Pharmaceutical Regulatory Affairs Market Snippet by Category
- 2.1.3. Pharmaceutical Regulatory Affairs Market Snippet by Product stage
- 2.1.4. Pharmaceutical Regulatory Affairs Market Snippet by Indication
- 2.1.5. Pharmaceutical Regulatory Affairs Market Snippet by Service Providers
- 2.1.6. Pharmaceutical Regulatory Affairs Market Snippet by Country
- 2.1.7. Pharmaceutical Regulatory Affairs Market Snippet by Region
- 2.2. Competitive Insights
3. Pharmaceutical Regulatory Affairs Key Market Trends
- 3.1. Pharmaceutical Regulatory Affairs Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Pharmaceutical Regulatory Affairs Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Pharmaceutical Regulatory Affairs Market Opportunities
- 3.4. Pharmaceutical Regulatory Affairs Market Future Trends
4. Pharmaceutical Regulatory Affairs Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Pharmaceutical Regulatory Affairs Market: COVID-19 Impact Analysis
- 5.1. Pre-COVID-19 Impact Analysis
- 5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments
6. Pharmaceutical Regulatory Affairs Market Landscape
- 6.1. Pharmaceutical Regulatory Affairs Market Share Analysis, 2022
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Pharmaceutical Regulatory Affairs Market - By Service
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Service, 2022 & 2030 (%)
- 7.1.2. Regulatory Consulting
- 7.1.3. Legal Representation
- 7.1.4. Regulatory Writing & Publishing (Writing, Publishing)
- 7.1.5. Product Registration & Clinical Trial services
- 7.1.6. Other
8. Pharmaceutical Regulatory Affairs Market - By Category
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Category, 2022 & 2030 (%)
- 8.1.2. Drugs
- 8.1.2.1. Innovator
- 8.1.2.2. Generics
- 8.1.2.3. Biologics
- 8.1.2.4. Biotech
- 8.1.2.5. ATMP
- 8.1.2.6. Biosimilars
9. Pharmaceutical Regulatory Affairs Market - By Product stage
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By Product stage, 2022 & 2030 (%)
- 9.1.2. Preclinical
- 9.1.3. Clinical Studies
- 9.1.4. PMA
10. Pharmaceutical Regulatory Affairs Market - By Indication
- 10.1. Overview
- 10.1.1. Segment Share Analysis, By Indication, 2022 & 2030 (%)
- 10.1.2. Preclinical
- 10.1.3. Clinical Studies
- 10.1.4. PMA
11. Pharmaceutical Regulatory Affairs Market - By Service Providers
- 11.1. Overview
- 11.1.1. Segment Share Analysis, By Service Providers, 2022 & 2030 (%)
- 11.1.2. In-house
- 11.1.3. Outsourcing
12. Pharmaceutical Regulatory Affairs Market- By Geography
- 12.1. Introduction
- 12.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
- 12.2. North America
- 12.2.1. Overview
- 12.2.2. Pharmaceutical Regulatory Affairs Key Manufacturers in North America
- 12.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 12.2.4. North America Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 12.2.5. North America Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
- 12.2.6. North America Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
- 12.2.7. North America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 12.2.8. North America Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
- 12.2.9. U.S.
- 12.2.9.1. Overview
- 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 12.2.9.3. U.S. Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 12.2.9.4. U.S. Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
- 12.2.9.5. U.S. Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
- 12.2.9.6. U.S. Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 12.2.9.7. U.S. Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
- 12.2.10. Canada
- 12.2.10.1. Overview
- 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 12.2.10.3. Canada Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 12.2.10.4. Canada Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
- 12.2.10.5. Canada Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
- 12.2.10.6. Canada Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 12.2.10.7. Canada Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
- 12.3. Europe
- 12.3.1. Overview
- 12.3.2. Pharmaceutical Regulatory Affairs Key Manufacturers in Europe
- 12.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 12.3.4. Europe Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 12.3.5. Europe Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
- 12.3.6. Europe Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
- 12.3.7. Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 12.3.8. Europe Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
- 12.3.9. Germany
- 12.3.9.1. Overview
- 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 12.3.9.3. Germany Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 12.3.9.4. Germany Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
- 12.3.9.5. Germany Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
- 12.3.9.6. Germany Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 12.3.9.7. Germany Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
- 12.3.10. Italy
- 12.3.10.1. Overview
- 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 12.3.10.3. Italy Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 12.3.10.4. Italy Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
- 12.3.10.5. Italy Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
- 12.3.10.6. Italy Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 12.3.10.7. Italy Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
- 12.3.11. United Kingdom
- 12.3.11.1. Overview
- 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 12.3.11.3. United Kingdom Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 12.3.11.4. United Kingdom Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
- 12.3.11.5. United Kingdom Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
- 12.3.11.6. United Kingdom Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 12.3.11.7. United Kingdom Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
- 12.3.12. France
- 12.3.12.1. Overview
- 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 12.3.12.3. France Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 12.3.12.4. France Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
- 12.3.12.5. France Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
- 12.3.12.6. France Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 12.3.12.7. France Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
- 12.3.13. Russia
- 12.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 12.3.13.2. Russia Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 12.3.13.3. Russia Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
- 12.3.13.4. Russia Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
- 12.3.13.5. Russia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 12.3.13.6. Russia Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
- 12.3.14. Netherlands
- 12.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 12.3.14.2. Netherlands Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 12.3.14.3. Netherlands Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
- 12.3.14.4. Netherlands Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
- 12.3.14.5. Netherlands Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 12.3.14.6. Netherlands Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
- 12.3.15. Sweden
- 12.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 12.3.15.2. Sweden Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 12.3.15.3. Sweden Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
- 12.3.15.4. Sweden Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
- 12.3.15.5. Sweden Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 12.3.15.6. Sweden Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
- 12.3.16. Poland
- 12.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 12.3.16.2. Poland Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 12.3.16.3. Poland Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
- 12.3.16.4. Poland Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
- 12.3.16.5. Poland Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 12.3.16.6. Poland Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
- 12.3.17. Rest of Europe
- 12.3.17.1. Overview
- 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 12.3.17.3. Rest of the Europe Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 12.3.17.4. Rest of the Europe Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
- 12.3.17.5. Rest of the Europe Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
- 12.3.17.6. Rest of the Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 12.3.17.7. Rest of the Europe Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
- 12.4. Asia Pacific (APAC)
- 12.4.1. Overview
- 12.4.2. Pharmaceutical Regulatory Affairs Key Manufacturers in Asia Pacific
- 12.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 12.4.4. Asia Pacific Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 12.4.5. Asia Pacific Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
- 12.4.6. Asia Pacific Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
- 12.4.7. Asia Pacific Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 12.4.8. Asia Pacific Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
- 12.4.9. India
- 12.4.9.1. Overview
- 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 12.4.9.3. India Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 12.4.9.4. India Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
- 12.4.9.5. India Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
- 12.4.9.6. India Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 12.4.9.7. India Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
- 12.4.10. China
- 12.4.10.1. Overview
- 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 12.4.10.3. China Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 12.4.10.4. China Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
- 12.4.10.5. China Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
- 12.4.10.6. China Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 12.4.10.7. China Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
- 12.4.11. Japan
- 12.4.11.1. Overview
- 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 12.4.11.3. Japan Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 12.4.11.4. Japan Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
- 12.4.11.5. Japan Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
- 12.4.11.6. Japan Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 12.4.11.7. Japan Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
- 12.4.12. South Korea
- 12.4.12.1. Overview
- 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 12.4.12.3. South Korea Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 12.4.12.4. South Korea Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
- 12.4.12.5. South Korea Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
- 12.4.12.6. South Korea Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 12.4.12.7. South Korea Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
- 12.4.13. Australia
- 12.4.13.1. Overview
- 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 12.4.13.3. Australia Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 12.4.13.4. Australia Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
- 12.4.13.5. Australia Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
- 12.4.13.6. Australia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 12.4.13.7. Australia Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
- 12.4.14. Thailand
- 12.4.14.1. Overview
- 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 12.4.14.3. Thailand Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 12.4.14.4. Thailand Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
- 12.4.14.5. Thailand Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
- 12.4.14.6. Thailand Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 12.4.14.7. Thailand Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
- 12.4.15. Indonesia
- 12.4.15.1. Overview
- 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 12.4.15.3. Indonesia Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 12.4.15.4. Indonesia Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
- 12.4.15.5. Indonesia Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
- 12.4.15.6. Indonesia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 12.4.15.7. Indonesia Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
- 12.4.16. Philippines
- 12.4.16.1. Overview
- 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 12.4.16.3. Philippines Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 12.4.16.4. Philippines Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
- 12.4.16.5. Philippines Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
- 12.4.16.6. Philippines Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 12.4.16.7. Philippines Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
- 12.4.17. Rest of APAC
- 12.4.17.1. Overview
- 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 12.4.17.3. Rest of APAC Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 12.4.17.4. Rest of APAC Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
- 12.4.17.5. Rest of APAC Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
- 12.4.17.6. Rest of APAC Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 12.4.17.7. Rest of APAC Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
- 12.5. Latin America
- 12.5.1. Overview
- 12.5.2. Pharmaceutical Regulatory Affairs Key Manufacturers in Latin America
- 12.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 12.5.4. Latin America Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 12.5.5. Latin America Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
- 12.5.6. Latin America Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
- 12.5.7. Latin America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 12.5.8. Latin America Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
- 12.5.9. Brazil
- 12.5.9.1. Overview
- 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 12.5.9.3. Brazil Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 12.5.9.4. Brazil Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
- 12.5.9.5. Brazil Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
- 12.5.9.6. Brazil Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 12.5.9.7. Brazil Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
- 12.5.10. Mexico
- 12.5.10.1. Overview
- 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 12.5.10.3. Mexico Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 12.5.10.4. Mexico Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
- 12.5.10.5. Mexico Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
- 12.5.10.6. Mexico Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 12.5.10.7. Mexico Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
- 12.5.11. Argentina
- 12.5.11.1. Overview
- 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 12.5.11.3. Argentina Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 12.5.11.4. Argentina Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
- 12.5.11.5. Argentina Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
- 12.5.11.6. Argentina Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 12.5.11.7. Argentina Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
- 12.5.12. Colombia
- 12.5.12.1. Overview
- 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 12.5.12.3. Colombia Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 12.5.12.4. Colombia Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
- 12.5.12.5. Colombia Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
- 12.5.12.6. Colombia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 12.5.12.7. Colombia Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
- 12.5.13. Rest of LATAM
- 12.5.13.1. Overview
- 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 12.5.13.3. Rest of LATAM Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 12.5.13.4. Rest of LATAM Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
- 12.5.13.5. Rest of LATAM Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
- 12.5.13.6. Rest of LATAM Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 12.5.13.7. Rest of LATAM Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
- 12.6. Middle East and Africa
- 12.6.1. Overview
- 12.6.2. Pharmaceutical Regulatory Affairs Key Manufacturers in Middle East and Africa
- 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 12.6.4. Middle East and Africa Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 12.6.5. Middle East and Africa Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
- 12.6.6. Middle East and Africa Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
- 12.6.7. Middle East and Africa Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 12.6.8. Middle East and Africa Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
- 12.6.9. Saudi Arabia
- 12.6.9.1. Overview
- 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 12.6.9.3. Saudi Arabia Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 12.6.9.4. Saudi Arabia Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
- 12.6.9.5. Saudi Arabia Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
- 12.6.9.6. Saudi Arabia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 12.6.9.7. Saudi Arabia Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
- 12.6.10. United Arab Emirates
- 12.6.10.1. Overview
- 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 12.6.10.3. United Arab Emirates Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 12.6.10.4. United Arab Emirates Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
- 12.6.10.5. United Arab Emirates Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
- 12.6.10.6. United Arab Emirates Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 12.6.10.7. United Arab Emirates Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
- 12.6.11. Israel
- 12.6.11.1. Overview
- 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 12.6.11.3. Israel Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 12.6.11.4. Israel Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
- 12.6.11.5. Israel Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
- 12.6.11.6. Israel Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 12.6.11.7. Israel Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
- 12.6.12. Turkey
- 12.6.12.1. Overview
- 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 12.6.12.3. Turkey Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 12.6.12.4. Turkey Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
- 12.6.12.5. Turkey Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
- 12.6.12.6. Turkey Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 12.6.12.7. Turkey Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
- 12.6.13. Algeria
- 12.6.13.1. Overview
- 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 12.6.13.3. Algeria Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 12.6.13.4. Algeria Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
- 12.6.13.5. Algeria Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
- 12.6.13.6. Algeria Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 12.6.13.7. Algeria Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
- 12.6.14. Egypt
- 12.6.14.1. Overview
- 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 12.6.14.3. Egypt Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 12.6.14.4. Egypt Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
- 12.6.14.5. Egypt Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
- 12.6.14.6. Egypt Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 12.6.14.7. Egypt Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
- 12.6.15. Rest of MEA
- 12.6.15.1. Overview
- 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 12.6.15.3. Rest of MEA Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 12.6.15.4. Rest of MEA Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
- 12.6.15.5. Rest of MEA Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
- 12.6.15.6. Rest of MEA Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 12.6.15.7. Rest of MEA Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
13. Key Vendor Analysis- Pharmaceutical Regulatory Affairs Industry
- 13.1. Competitive Dashboard
- 13.2. Company Profiles
- 13.2.1. Freyr
- 13.2.2. IQVIA Inc
- 13.2.3. ICON plc
- 13.2.4. WuXi AppTec
- 13.2.5. Charles River Laboratories
- 13.2.6. Labcorp Drug Development
- 13.2.7. Parexel International Corporation
- 13.2.8. Pharmalex GmbH
- 13.2.9. Pharmexon
- 13.2.10. Genpact
14. 360 Degree Analyst View
15. Appendix
- 15.1. Research Methodology
- 15.2. References
- 15.3. Abbreviations
- 15.4. Disclaimer
- 15.5. Contact Us
List of Tables
- TABLE List of data sources
- TABLE Market drivers; Impact Analysis
- TABLE Market restraints; Impact Analysis
- TABLE Pharmaceutical Regulatory Affairs Market: Service Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Service
- TABLE Global Pharmaceutical Regulatory Affairs Market, by Service 2018-2030 (USD Million)
- TABLE Pharmaceutical Regulatory Affairs Market: Category Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Category
- TABLE Global Pharmaceutical Regulatory Affairs Market, by Category 2018-2030 (USD Million)
- TABLE Pharmaceutical Regulatory Affairs Market: Product stage Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Product stage
- TABLE Global Pharmaceutical Regulatory Affairs Market, by Product stage 2018-2030 (USD Million)
- TABLE Pharmaceutical Regulatory Affairs Market: Indication Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Indication
- TABLE Global Pharmaceutical Regulatory Affairs Market, by Indication 2018-2030 (USD Million)
- TABLE Pharmaceutical Regulatory Affairs Market: Service Providers Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Service Providers
- TABLE Global Pharmaceutical Regulatory Affairs Market, by Service Providers 2018-2030 (USD Million)
- TABLE Pharmaceutical Regulatory Affairs Market: Regional snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Region
- TABLE Global Pharmaceutical Regulatory Affairs Market, by Region 2018-2030 (USD Million)
- TABLE North America Pharmaceutical Regulatory Affairs Market, by Country, 2018-2030 (USD Million)
- TABLE North America Pharmaceutical Regulatory Affairs Market, by Service, 2018-2030 (USD Million)
- TABLE North America Pharmaceutical Regulatory Affairs Market, by Category, 2018-2030 (USD Million)
- TABLE North America Pharmaceutical Regulatory Affairs Market, by Product stage, 2018-2030 (USD Million)
- TABLE North America Pharmaceutical Regulatory Affairs Market, by Indication, 2018-2030 (USD Million)
- TABLE North America Pharmaceutical Regulatory Affairs Market, by Service Providers, 2018-2030 (USD Million)
- TABLE Europe Pharmaceutical Regulatory Affairs Market, by Country, 2018-2030 (USD Million)
- TABLE Europe Pharmaceutical Regulatory Affairs Market, by Service, 2018-2030 (USD Million)
- TABLE Europe Pharmaceutical Regulatory Affairs Market, by Category, 2018-2030 (USD Million)
- TABLE Europe Pharmaceutical Regulatory Affairs Market, by Product stage, 2018-2030 (USD Million)
- TABLE Europe Pharmaceutical Regulatory Affairs Market, by Indication, 2018-2030 (USD Million)
- TABLE Europe Pharmaceutical Regulatory Affairs Market, by Service Providers, 2018-2030 (USD Million)
- TABLE Asia Pacific Pharmaceutical Regulatory Affairs Market, by Country, 2018-2030 (USD Million)
- TABLE Asia Pacific Pharmaceutical Regulatory Affairs Market, by Service, 2018-2030 (USD Million)
- TABLE Asia Pacific Pharmaceutical Regulatory Affairs Market, by Category, 2018-2030 (USD Million)
- TABLE Asia Pacific Pharmaceutical Regulatory Affairs Market, by Product stage, 2018-2030 (USD Million)
- TABLE Asia Pacific Pharmaceutical Regulatory Affairs Market, by Indication, 2018-2030 (USD Million)
- TABLE Asia Pacific Pharmaceutical Regulatory Affairs Market, by Service Providers, 2018-2030 (USD Million)
- TABLE Latin America Pharmaceutical Regulatory Affairs Market, by Country, 2018-2030 (USD Million)
- TABLE Latin America Pharmaceutical Regulatory Affairs Market, by Service, 2018-2030 (USD Million)
- TABLE Latin America Pharmaceutical Regulatory Affairs Market, by Category, 2018-2030 (USD Million)
- TABLE Latin America Pharmaceutical Regulatory Affairs Market, by Product stage, 2018-2030 (USD Million)
- TABLE Latin America Pharmaceutical Regulatory Affairs Market, by Indication, 2018-2030 (USD Million)
- TABLE Latin America Pharmaceutical Regulatory Affairs Market, by Service Providers, 2018-2030 (USD Million)
- TABLE Middle East and Africa Pharmaceutical Regulatory Affairs Market, by Country, 2018-2030 (USD Million)
- TABLE Middle East and Africa Pharmaceutical Regulatory Affairs Market, by Service, 2018-2030 (USD Million)
- TABLE Middle East and Africa Pharmaceutical Regulatory Affairs Market, by Category, 2018-2030 (USD Million)
- TABLE Middle East and Africa Pharmaceutical Regulatory Affairs Market, by Product stage, 2018-2030 (USD Million)
- TABLE Middle East and Africa Pharmaceutical Regulatory Affairs Market, by Indication, 2018-2030 (USD Million)
- TABLE Middle East and Africa Pharmaceutical Regulatory Affairs Market, by Service Providers, 2018-2030 (USD Million)
